Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphodiesterase 2 (PDE2) is an enzyme that hydrolyzes both cAMP and cGMP, playing a crucial role in regulating intracellular cyclic nucleotide levels and signal transduction pathways. Its unique allosteric activation by cGMP makes it a distinct member of the phosphodiesterase family. It is expressed widely across tissues and is a target for drug development.
Selective inhibitors of PDE2 can increase intracellular cAMP and cGMP levels by preventing their degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphodiesterase 2 (PDE2).